RecruitingNCT07483203

A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease

Clinical Implications of Pulmonary Vascular Disease in Valvular Heart Disease


Sponsor

Mayo Clinic

Enrollment

600 participants

Start Date

Apr 28, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Echocardiogram for people with pulmonary vascular disease and valvular heart disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEchocardiogram

An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07483203


Related Trials